ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 807,22
1,48%
DAX
18 518,03
-0,44%
Brent Oil
83,54
-0,95%
Bitcoin
64 569,00
-0,44%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
21/07/201414h00Business WireTeva Completes Acquisition of Labrys: Opens Door to a Strong & Novel Migraine Prevention & Treatment Franchise within its CNS...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201417h53Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201414h00Business WireTeva to Report Second Quarter 2014 Financial Results on July 31, 2014NYSE:TEVATeva Pharmaceutical Industries Ltd
16/07/201414h46Business WireLeading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting ProposalsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/07/201414h00Business WireTeva Announces FDA Acceptance of NDA Filing for Investigational Short-Acting Beta-Agonist (SABA) Inhaler (Albuterol MDPI)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/07/201423h30Dow Jones NewsADR Shares End Higher; America Movil, Teva Shares Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd.
09/07/201412h43Dow Jones NewsEU Fines Servier, Generic Drug-Makers EUR427.7 Million for Violating Antitrust RulesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/07/201408h00Business WireTeva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing Authorization in Several Eu...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/07/201414h39Business WireADDING MULTIMEDIA Teva Files Citizen Petition with the U.S. Food & Drug Administration (FDA) Regarding the Complexity of COPA...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/07/201414h00Business WireTeva Files Citizen Petition with the U.S. Food & Drug Administration (FDA) Regarding the Complexity of COPAXONE® (glatiramer...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/06/201414h59Business WireTeva Reaches Settlement in ProAir® HFA Patent CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201423h07Dow Jones NewsADR Shares End HigherNYSE:TEVATeva Pharmaceutical Industries Ltd.
17/06/201414h00Business WireTeva Reaches Settlements In NUVIGIL® Patent CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
13/06/201414h51Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd.
12/06/201422h57Dow Jones NewsAppeals Court Backs Teva Over Hepatitis Drug's PatentNYSE:TEVATeva Pharmaceutical Industries Ltd.
12/06/201421h32Business WireTeva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
10/06/201417h04PR Newswire (US)Energtek Further Strengthens Management TeamNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/201414h00Business WireFDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
05/06/201415h07Business WireTeva to Present at the Goldman Sachs 35th Annual Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
03/06/201413h30Business WireTeva to Acquire Labrys Biologics, Inc.: Novel Migraine Prophylaxis Treatment Adds Significant New Dimension to Teva’s Growi...NYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/201423h13Dow Jones NewsADR Shares End MixedNYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/201420h24Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/201415h43Business WireTeva Announces New Organizational Structure & Senior Leadership Changes, Enabling the Global Integration of the Company & Pos...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/05/201415h15Business WireTeva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generi...NYSE:TEVATeva Pharmaceutical Industries Ltd
29/05/201414h00Business WireTeva to Present at the Jefferies 2014 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
27/05/201420h50Business WireTeva Announces Favorable European Patent Office Ruling in COPAXONE® Patent ProceedingNYSE:TEVATeva Pharmaceutical Industries Ltd
23/05/201414h00Business WireTeva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose CounterNYSE:TEVATeva Pharmaceutical Industries Ltd
23/05/201408h30Business WireTeva & Active Biotech to Continue with the Development of Nerventra® (Laquinimod) for Multiple Sclerosis Following Confirmat...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/05/201414h21Dow Jones NewsMylan Applauds Court's Dismissal of Teva's Suit Against FDANYSE:TEVATeva Pharmaceutical Industries Ltd.
15/05/201414h00Business WireTeva to Present at the UBS Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
NYSE
MRK
Merck
EU
DG
Vinci
EU
ACA
Credit Agricole
EU
RNO
Renault
EU
VK
Vallourec
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés